Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock par value $0.012 per share
-
Shares outstanding
-
41,009,592
-
Total 13F shares
-
220,940
-
Share change
-
+28,610
-
Total reported value
-
$1,841,000
-
Put/Call ratio
-
11%
-
Price per share
-
$8.34
-
Number of holders
-
23
-
Value change
-
+$300,003
-
Number of buys
-
8
-
Number of sells
-
8
Institutional Holders of ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) as of Q2 2016
As of 30 Jun 2016,
ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
220,940 shares.
The largest 10 holders included
TOCQUEVILLE ASSET MANAGEMENT L.P., MORGAN STANLEY, BARCLAYS PLC, MILLENNIUM MANAGEMENT LLC, PNC FINANCIAL SERVICES GROUP, INC., Cutler Group LP, WELLS FARGO & COMPANY/MN, Acrospire Investment Management LLC, SIMPLEX TRADING, LLC, and FineMark National Bank & Trust.
This page lists
23
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.